Fulcrum Therapeutics, Inc. (FULC)
Since Aug 26, 2019, Fulcrum Therapeutics, Inc. (FULC) has reported earnings 28 times. On average the shares move ±13.42% post-earnings, with a positive reaction 57.1% of the time. Its largest post-earnings gain was +125.33% (Aug 10, 2021) and its largest decline was -48.01% (Aug 11, 2020). The next earnings report is predicted for 2026-07-28 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
28
Avg Abs. Movement
±13.42%
Positive %
57.1%
Negative %
42.9%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | ☀ PRE | $7.49 | $7.89 | $7.72 | 1,145,300 | -1.53% | open_in_new |
| Feb 24, 2026 | ☀ PRE | $9.65 | $10.42 | $8.58 | 4,163,200 | -21.21% | open_in_new |
| Oct 29, 2025 | ☀ PRE | $9.72 | $10.04 | $9.36 | 2,864,400 | -6.4% | open_in_new |
| Jul 29, 2025 | ☀ PRE | $7.66 | $8.50 | $7.59 | 7,188,700 | -2.82% | open_in_new |
| May 01, 2025 | ☀ PRE | $3.84 | $4.69 | $4.38 | 926,600 | +13.77% | open_in_new |
| Feb 25, 2025 | ☀ PRE | $3.58 | $3.80 | $3.70 | 444,600 | +0% | open_in_new |
| Nov 13, 2024 | ☀ PRE | $3.94 | $3.94 | $3.56 | 870,100 | -2.2% | open_in_new |
| Jul 31, 2024 | ☀ PRE | $8.95 | $9.73 | $9.28 | 1,466,100 | +10.34% | open_in_new |
| May 13, 2024 | ☀ PRE | $8.35 | $8.50 | $7.35 | 2,034,500 | -1.61% | open_in_new |
| Feb 27, 2024 | ☀ PRE | $10.00 | $10.50 | $10.18 | 1,506,700 | +4.62% | open_in_new |
| Nov 07, 2023 | ☀ PRE | $3.74 | $4.57 | $4.29 | 1,200,400 | +19.5% | open_in_new |
| Aug 03, 2023 | ☀ PRE | $3.99 | $4.31 | $3.85 | 710,000 | +0.79% | open_in_new |
| May 15, 2023 | ☀ PRE | $3.41 | $3.67 | $3.64 | 930,700 | +11.31% | open_in_new |
| Mar 09, 2023 | ☀ PRE | $5.08 | $5.70 | $4.82 | 3,385,200 | -23% | open_in_new |
| Nov 08, 2022 | ☀ PRE | $6.47 | $6.67 | $6.45 | 543,500 | +14.97% | open_in_new |
| Aug 11, 2022 | ☀ PRE | $6.92 | $8.12 | $7.57 | 548,900 | -2.45% | open_in_new |
| May 09, 2022 | ☀ PRE | $8.68 | $9.29 | $7.66 | 1,324,300 | -11.24% | open_in_new |
| Mar 03, 2022 | ☀ PRE | $10.91 | $12.04 | $11.70 | 2,647,800 | +5.41% | open_in_new |
| Nov 04, 2021 | ☀ PRE | $20.74 | $21.48 | $21.15 | 1,028,300 | +3.27% | open_in_new |
| Aug 10, 2021 | ☀ PRE | $13.21 | $22.09 | $18.77 | 104,744,200 | +125.33% | open_in_new |
| May 06, 2021 | ☀ PRE | $10.07 | $10.60 | $10.58 | 86,200 | +5.06% | open_in_new |
| Mar 04, 2021 | ☀ PRE | $14.28 | $14.34 | $12.50 | 210,700 | -14.32% | open_in_new |
| Nov 10, 2020 | ☀ PRE | $10.86 | $11.07 | $10.94 | 145,400 | +1.11% | open_in_new |
| Aug 11, 2020 | ☀ PRE | $12.00 | $12.00 | $8.90 | 2,026,700 | -48.01% | open_in_new |
| May 13, 2020 | ☀ PRE | $15.06 | $20.00 | $16.48 | 349,400 | +10.53% | open_in_new |
| Mar 05, 2020 | ☀ PRE | $18.95 | $18.95 | $18.50 | 74,700 | +2.78% | open_in_new |
| Nov 14, 2019 | ☀ PRE | $7.82 | $8.19 | $7.64 | 93,500 | -3.29% | open_in_new |
| Aug 26, 2019 | ☀ PRE | $10.40 | $11.03 | $11.03 | 33,400 | +8.78% | open_in_new |
Earnings Count
28
Total earnings in dataset
Avg Abs. Movement
±13.42%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G | 20260610 | open_in_new SEC.gov |
| 8-K | 20260604 | open_in_new SEC.gov |
| 8-K | 20260601 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 3 | 20260501 | open_in_new SEC.gov |
| 4 | 20260501 | open_in_new SEC.gov |
| ARS | 20260430 | open_in_new SEC.gov |
| DEF 14A | 20260430 | open_in_new SEC.gov |
| DEFA14A | 20260430 | open_in_new SEC.gov |
Frequently asked about FULC earnings
When does Fulcrum Therapeutics, Inc. report earnings next? expand_more
Fulcrum Therapeutics, Inc. (FULC)'s next earnings date is approximate for 2026-07-28. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does FULC stock move after earnings? expand_more
Over 28 reports, FULC has moved an average of ±13.42% the session after earnings, closing higher 57.1% of the time.
What was FULC's biggest post-earnings move? expand_more
FULC's largest post-earnings gain on record was +125.33% on Aug 10, 2021, and its largest decline was -48.01% on Aug 11, 2020.
Where can I find Fulcrum Therapeutics, Inc.'s SEC filings? expand_more
All of Fulcrum Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right